Matthew Biever, DO
Psychiatry · Lancaster, PANPI 1023227741
Payments from drug & device makers
Across 546 payments — averaging $135.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$39K
- Axsome Therapeutics, Inc.$20K
- Otsuka America Pharmaceutical, Inc.$8K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Teva Pharmaceuticals USA, Inc.$863
- Neurocrine Biosciences, Inc.$784
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 140 | $39,233 |
| Axsome Therapeutics, Inc. | 26 | $19,997 |
| Otsuka America Pharmaceutical, Inc. | 54 | $8,300 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 66 | $1,438 |
| Teva Pharmaceuticals USA, Inc. | 44 | $863 |
| Neurocrine Biosciences, Inc. | 47 | $784 |
| Johnson & Johnson | 52 | $783 |
| Alkermes, Inc. | 36 | $738 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $334 |
| Lundbeck LLC | 14 | $247 |
| Vanda Pharmaceuticals Inc. | 8 | $227 |
| Ironshore Pharmaceuticals Inc. | 7 | $155 |
| Supernus Pharmaceuticals, Inc. | 6 | $83 |
| Corium, LLC | 4 | $79 |
| Sunovion Pharmaceuticals Inc. | 7 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Indivior Inc. | 3 | $47 |
| Noven Pharmaceuticals, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $27 |
| Adlon Therapeutics L.p. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $24 |
| Sage Therapeutics, LLC | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $22 |
| Neuronetics, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Neos Therapeutics, LP | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Tris Pharma Inc | 1 | $13 |
How this compares
$73,720 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Lancaster
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.